World Journal of Hepatology - Baishideng Publishing Group

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Wong R, Yuan LY. Sarcopenia and metabolic dysfunction associated steatotic liver disease: Time to address both. World J Hepatol 2024; 16(6): 871-877 [PMID: 38948439 DOI: 10.4254/wjh.v16.i6.871]
URL:	https://www.wjgnet.com/1948-5182/full/v16/i6/871.htm

(116) (165) (0) (0) (0) (6) (3972) (22)

Number	Citing Articles
1	Sizhe Wan, Mingkai Li, Wanjun Li, Yuexiang Ren, Yuankai Wu, Qingtian Luo, Wei Gong. Development and validation of a multimodal model integrating gut microbiota and metabolite for identifying sarcopenia in patients with MASLD: a study from two centers in China. Nutrition Journal 2025; 24(1) doi: 10.1186/s12937-025-01198-2
2	Yanyan Xuan, Fangfang He, Qing Liu, Dandan Dai, Dingting Wu, Yanmei Shi, Qi Yao. Elevated GGT to HDL ratio as a marker for the risk of NAFLD and liver fibrosis. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-024-84649-w
3	Jiawen Dong, Kaitlyn M J H Dennis, Radha Venkatakrishnan, Leanne Hodson, Jeremy W Tomlinson. The Impact of Estrogen Deficiency on Liver Metabolism: Implications for Hormone Replacement Therapy. Endocrine Reviews 2025; 46(6) doi: 10.1210/endrev/bnaf018
4	Carlos Jiménez-Cortegana, Soledad López-Enríquez, Gonzalo Alba, Consuelo Santa-María, Gracia M. Martín-Núñez, Francisco J. Moreno-Ruiz, Sergio Valdés, Sara García-Serrano, Cristina Rodríguez-Díaz, Ailec Ho-Plágaro, María I. Fontalba-Romero, Eduardo García-Fuentes, Lourdes Garrido-Sánchez, Víctor Sánchez-Margalet. The Expression of Genes Related to Reverse Cholesterol Transport and Leptin Receptor Pathways in Peripheral Blood Mononuclear Cells Are Decreased in Morbid Obesity and Related to Liver Function. International Journal of Molecular Sciences 2024; 25(14) doi: 10.3390/ijms25147549
5	Fan Zhang, Wenjian Li. Correlation Between Metabolic Dysfunction-Associated Steatotic Liver Disease and the Risk of Urinary Incontinence in Adult Women. International Journal of Women's Health 2024; doi: 10.2147/IJWH.S489959
6	思阅李. Identification of Shared Candidate Diagnostic Biomarkers for NAFLD and Sarcopenia Based on Bioinformatics and Machine Learning. Advances in Clinical Medicine 2026; 16(04) doi: 10.12677/acm.2026.1641725
7	Yan Li, Wei Feng, Xiaojie Sun, Yujie Dong. Causal and mediating link between sarcopenia and nonalcoholic fatty liver disease: A bidirectional two-sample, two-step Mendelian randomization study. Nutrition, Metabolism and Cardiovascular Diseases 2025; 35(12) doi: 10.1016/j.numecd.2025.104207
8	Kai-Rui Wan, Cheng Qian, Li-Mei Liu. Bidirectional regulation between the endocrine system and liver: From mechanisms to multidisciplinary clinical care. World Journal of Gastroenterology 2026; 32(6): 115232 doi: 10.3748/wjg.v32.i6.115232 Abstract(38) \| Core Tip(33) \| Full Article(HTML)(185) \| Full Article (PDF)-2573K(55) \| Full Article with Cover (PDF)-3087K(28) \| Full Article (XML)-42K(31) \| Audio-1946K(14) \| Peer-Review Report-241K(26) \| Answering Reviewers-160K(48) \| Times Cited (0) \| Total Visits (339) \| Open
9	Yea-Chan Lee, Hye Sun Lee, Soyoung Jeon, Yae-Ji Lee, Yu-Jin Kwon, Ji-Won Lee. Assessing Nutritional Factors for Metabolic Dysfunction-Associated Steatotic Liver Disease via Diverse Statistical Tools. Diabetes & Metabolism Journal 2026; 50(1) doi: 10.4093/dmj.2025.0026
10	Abdulrahman Ismaiel, Vera Ciornolutchii, Stefan‐Lucian Popa, Dan L. Dumitrascu. Can ammonia scavenging treat MASLD? Evaluating the evidence for L‐ornithine L‐aspartate—A systematic review. European Journal of Clinical Investigation 2026; 56(2) doi: 10.1111/eci.70185
11	Shinya Sato, Hiroaki Takaya, Tadashi Namisaki, Tatsuya Nakatani, Jun-ichi Hanatani, Yuki Tsuji, Koh Kitagawa, Norihisa Nishimura, Kosuke Kaji, Hitoshi Yoshiji. Diabetes as a Risk Factor for Sarcopenia in Patients with MASH-Related Cirrhosis. Journal of Clinical Medicine 2025; 14(24) doi: 10.3390/jcm14248691
12	Sampada, Mohammad Naseem, Mehul Solanki, Ragini Sharma, Carol Singh, Aalam Sohal. Pathophysiology of depression and anxiety in metabolic dysfunction-associated steatotic liver disease. World Journal of Gastrointestinal Pathophysiology 2025; 16(4): 111029 doi: 10.4291/wjgp.v16.i4.111029 Abstract(88) \| Core Tip(73) \| Full Article(HTML)(583) \| Full Article (PDF)-1726K(63) \| Full Article with Cover (PDF)-2003K(36) \| Full Article (XML)-341K(31) \| Audio-2835K(13) \| Peer-Review Report-278K(35) \| Answering Reviewers-187K(39) \| Times Cited (2) \| Total Visits (835) \| Open
13	Yusuf Yilmaz, Alina M. Allen, Jérôme Boursier, Juan P. Arab. Association of Metabolic Dysfunction-Associated Steatotic Liver Disease with Extrahepatic Cancers and Sarcopenia. Clinics in Liver Disease 2026; 30(2) doi: 10.1016/j.cld.2025.12.002
14	Fan Zhang, Longgen Liu, Wenjian Li. Correlation of sarcopenia with progression of liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: a study from two cohorts in China and the United States. Nutrition Journal 2025; 24(1) doi: 10.1186/s12937-025-01081-0
15	Consensus guidelines for the diagnosis and management of metabolic dysfunction-associated steatotic liver disease in adult Asian Indians with type 2 diabetes. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2025; 19(3) doi: 10.1016/j.dsx.2025.103209
16	Niki G. Mourelatou, Triada Bali, Magdalini Adamantou, Lampros Chrysavgis, Christos Chologkitas, Margarita Sarri, Dimitra Pavlopoulou, Georgios Schinas, Theodoros Androutsakos, Georgia Sypsa, Dimitrios S. Karagiannakis, George Papatheodoridis, Nikolaos Tentolouris, Anastasia N. Mavrogiannaki, Evangelos Cholongitas. Evaluation of Sarcopenic Obesity in Patients with MASLD. Medical Sciences 2026; 14(2) doi: 10.3390/medsci14020257
17	M. Yu. Nadinskaia, S. V. Okovityi, V. A. Prikhodko, A. F. Sheptulina, T. A. Deeva, M. V. Maevskaya, M. F. Osipenko. Clinical significance of hyperammonemia in non-alcoholic fatty liver disease. Meditsinskiy sovet = Medical Council 2026; doi: 10.21518/ms2026-204
18	Shuangshuang Hou, Yang Yu, Nanbo Li, Wenjing Yu, Zhiyuan Dai, He Li, Lianyi Guo, Jiajun Yin, Ju Wu. Preoperative albumin-bilirubin grade combined with sarcopenia predicts long-term outcomes after laparoscopic gastrectomy for advanced gastric cancer. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-04173-7
19	Marwan S Al-Nimer. Sarcopenia and metabolic dysfunction-associated steatotic liver disease: The role of exercise-related biomarkers. World Journal of Hepatology 2025; 17(2): 101165 doi: 10.4254/wjh.v17.i2.101165 Abstract(407) \| Core Tip(443) \| Full Article(HTML)(1909) \| Full Article (PDF)-544K(160) \| Full Article with Cover (PDF)-739K(154) \| Full Article (XML)-64K(106) \| Audio-1168K(12) \| Peer-Review Report-251K(89) \| Answering Reviewers-65K(83) \| Times Cited (2) \| Total Visits (3046) \| Open
20	Noha M. Gamil, Habiba A. Elsayed, Esraa T. Salah, Heba A. Mostafa, Riham A. El-Shiekh, Heba R. Ghaiad, Hebatollah E. Eitah. Decoding the mechanistic basis of liver–muscle communication in health and disease. Naunyn-Schmiedeberg's Archives of Pharmacology 2026; 399(8) doi: 10.1007/s00210-026-05015-3
21	Hiroyuki Ito, Chizuko Yukawa, Toshiko Mori, Chiaki I, Mizuki Matsushita, Suzuko Matsumoto, Hideyuki Inoue, Shinichi Antoku, Tomoko Yamasaki, Kenichi Nishio, Sayuri Miura. Fibrosis-4 (FIB-4) Index Is Associated With Skeletal Muscle Mass in Japanese Patients With Type 2 Diabetes: A Single-Center Retrospective Cross-Sectional Study. Cureus 2026; doi: 10.7759/cureus.107785
22	Anoushka Shenoy, Aijaz Ahmed, Donghee Kim. Extrahepatic manifestation of metabolic dysfunction-associated steatotic liver disease. Metabolism and Target Organ Damage 2025; 5(3) doi: 10.20517/mtod.2025.73